no weight loss on compounded semaglutide Woman shares journey of and gain after using Embody | Personalized GLP-1 Weight

By month two, something shifted

WADA Prohibition Status Based on WADAs prohibition categories: GLP3 likely falls under Section S0 (Non-Approved Substances) of the WADA Prohibited List, which includes: Any pharmacological substance not approved by governmental regulatory health authorities for human therapeutic use Drugs under preclinical or clinical development Substances without current regulatory approval from any health authority worldwide Implications for competitive athletes: Prohibited at all times (in-competition and out-of-competition) No Therapeutic Use Exemptions available for unapproved substances Use could result in anti-doping rule violations and sanctions Detection methods under development as clinical trials progress Research Classification: GLP3 is available exclusively for use in FDA-approved clinical trials under Investigational New Drug applications

That's an average of 71.2 pounds lost

This is significant, it means a planned 1mg dose is effectively delivering 0.75mg

1,22 Pharmacists can play a central role in monitoring, counseling on, and facilitating access, thereby supporting adherence and optimizing clinical outcomes

Remove air bubbles